SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-17-002461
Filing Date
2017-03-16
Accepted
2017-03-16 16:29:57
Documents
73
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2016_actiniumpharma.htm 10-K 1455947
2 FIFTH AMENDMENT TO THE 2013 AMENDED AND RESTATED STOCK PLAN f10k2016ex10lix_actinium.htm EX-10.59 9576
3 AMENDMENT TO EMPLOYMENT AGREEMENT - DRAGAN CICIC f10k2016ex10lx_actinium.htm EX-10.60 10483
4 AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK, DA f10k2016ex10lxi_actinium.htm EX-10.61 5317
5 AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK, DA f10k2016ex10lxii_actinium.htm EX-10.62 5317
6 WARRANT TO PURCHASE COMMON STOCK OF ACTINIUM PHARMACEUTICALS, INC., DATED MARCH f10k2016ex10lxiii_actinium.htm EX-10.63 107475
7 OFFER LETTER - DR. MARK S. BERGER f10k2016ex10lxiv_actinium.htm EX-10.64 38092
8 CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT f10k2016ex10lxv_actinium.htm EX-10.65 53976
9 INDEMNIFICATION AGREEMENT - MARK S. BERGER f10k2016ex10lxvi_actinium.htm EX-10.66 86814
10 CONSENT OF GBH CPAS, PC f10k2016ex23i_actinium.htm EX-23.1 3177
11 CERTIFICATION f10k2016ex31i_actinium.htm EX-31.1 10467
12 CERTIFICATION f10k2016ex31ii_actinium.htm EX-31.2 10285
13 CERTIFICATION f10k2016ex32i_actinium.htm EX-32.1 3198
14 CERTIFICATION f10k2016ex32ii_actinium.htm EX-32.2 3262
21 GRAPHIC ex10lx_001.jpg GRAPHIC 12708
22 GRAPHIC ex10lxi_001.jpg GRAPHIC 12708
  Complete submission text file 0001213900-17-002461.txt   5574138

Data Files

Seq Description Document Type Size
15 XBRL INSTANCE FILE atnm-20161231.xml EX-101.INS 800845
16 XBRL SCHEMA FILE atnm-20161231.xsd EX-101.SCH 52981
17 XBRL CALCULATION FILE atnm-20161231_cal.xml EX-101.CAL 30392
18 XBRL DEFINITION FILE atnm-20161231_def.xml EX-101.DEF 190236
19 XBRL LABEL FILE atnm-20161231_lab.xml EX-101.LAB 473507
20 XBRL PRESENTATION FILE atnm-20161231_pre.xml EX-101.PRE 310648
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36374 | Film No.: 17694926
SIC: 2834 Pharmaceutical Preparations